Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pretty funny.
Once the public is aware we are on track which happens Friday imo, we will run alright.
NH from last Q
"and are well positioned to file the first of our abuse resistant opioid products by the end of this year. We have emerged as one of the leaders in the development of abuse deterrent opioids. "
If we get a statement similar to this on Friday, we fly
NH from last Q
"and are well positioned to file the first of our abuse resistant opioid products by the end of this year. We have emerged as one of the leaders in the development of abuse deterrent opioids. "
Good thinking, i would not wait either. Silly to wait for everyone to jump on board, the opportunity for the huge gains will be gone.
You are welcome to wait for all the confirmation that is coming. By the time we have "one credible independent model", you will pay 10x current value at a min. imo
I will buy now, just as I did below a dime.
Oh I think it will, traditionally they do.
I also am aware we don't for sure until we see the pr, but NH I believe gave us all a very lg hint with his own wallet.
I know I bought all I could after his inside buys, I have a bunch from 3 years back , but added every time I had an extra 5 or 600 dollars over the last month.
GLTU
Yup ,heard it would never hold above dime also. lol
Say what ART method do you think is superior to Elites and why do you think it will be more effective?
You must think there are better products out there, which ones, why and where are they at in getting thier product to market?
May or may nor ever use all the shares.
When Elites ART hits the market some 9 or so months from now it won't matter, the market is huge.
Doesn't seem NH is very worried, just bought more.
Now why would he do that if he was worried about it?
OK show me one where the CEO took his own money and spent well over 200k , sold non and then R/s it. Also one who took shares for pay.
Ya happens all the time.
I would do that to if was a ceo, I am sure my wife would love it. lol
Most likely Monday.
LOL,
Everyone wants instant riches, and lots of pr's.
IMO it will be those who buy and hold like NH that will win.
No I don't look at one days trading action.
Although I think it will do much better, I would be very happy with the YTD returns every year for the next 4 or 5 years.
Dilution is an issue if they don't get their ART to market. I am here because i believe they will.
So does NH, those the buys for his IRA to the tune of just short 1/4 of a million dollars.
If I thought they would not get their tech to market, I would not be here and would not be buying small amounts when able.
Lots of folks expecting negative news it seems.
If this is the case what sense does it make for NH to buy more shares.
Would he not wait and pick them up after negative news is pr'd?
I would!
(BTW I will bet they are taking shares for salary like NH)
We don't know, I expect it has already happened.
What do you think the price will go to once they file in Dec?
I would love to hear we got a green light and everything is on schedule. NH is extremely driven to get ART to market, and just showed huge confidence in the tech/company by buying more. I do not think the down side is that great even if we have to wait 6 months, maybe test .26 again. The up side is much much larger imo.
There is a possibility that we meet with the FDA sometime this month, and we are given the date and must wait a little longer.
Me I am buying with CEO when ever possible.
I agree,
it would be poetic justice to have a huge pr drop and the 800k be bought before it could be removed.
GLTU
Be interesting to see what would happen if someone was able to buy that many at once.
Of this I am confident, then person putting those shares up does not want to sell those shares.
It is manipulation and will continue as long as volume is weak.
GLTA Longs
Seems a few folks here think the price is a day to day representation of the body of work of the company. IMO the company has made huge progress on many fronts over the last few months. just like they had when the price was below a dime.
WHat will happen imo, is all of a sudden investors will take notice, and the stock will fly, never to trade in this range again, like the .07's of old.
.097 to .3 , very nice return so far this year.
GREEEEN
CEO speak,
What speaks louder than buying with your families IRA?
What speaks louder than not selling even one share in the .90's?
Someone picking up shares at .2980, my guess those look very cheap come this time next week.
GLTA Longs
I am hear a lot of the same things I heard at .07.
Yup and it won't be long till the 50 day shoots up and crosses it.
Last chance to buy at these prices . imo
News trumps charts, and NH is about to step to the mic and tell us all what the FDA had to say.
By the time everyone knows it, you will be paying north of 5 bucks a share.
But hey, wait and buy then. IMO
GLTA Longs
Here some CEO speak from a few weeks back.
Statement of Changes in Beneficial Ownership (4)
Print
Alert
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
Hakim Nasrat A 2. Issuer Name and Ticker or Trading Symbol
ELITE PHARMACEUTICALS INC /NV/ [ ELTP ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__ X __ Director __ X __ 10% Owner
__ X __ Officer (give title below) _____ Other (specify below)
CEO & President
(Last) (First) (Middle)
165 LUDLOW AVE. 3. Date of Earliest Transaction (MM/DD/YYYY)
10/17/2014
(Street)
NORTHVALE, NJ 07647
(City) (State) (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 8. Price of Derivative Security
(Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants $0.0625 10/17/2014 J (1) 759695 10/30/2009 10/30/2016 Common Stock 759695 $0 759695 D
Explanation of Responses:
( 1) Disposition of warrants to members of Epic Pharma, LLC
Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Hakim Nasrat A
165 LUDLOW AVE.
NORTHVALE, NJ 07647 X X CEO & President
Signatures
Nasrat Hakim 10/21/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Elite Pharmaceuticals, Inc. (QB) (OTCBB:ELTP)
Historical Stock Chart
1 Year : From Nov 2013 to Nov 2014
Click Here for more Elite Pharmaceuticals, Inc. (QB) Charts.
Elite Pharmaceuticals, Inc. (QB) (OTCBB:ELTP)
Intraday Stock Chart
Today : Friday 7 November 2014
Click Here for more Elite Pharmaceuticals, Inc. (QB) Charts.
Its so simple its brilliant.
Plug and play for all opioids.
Even if Elite uses every possible os share, the potential for the stock is huge.
IMO dilution is not an issue, if it were a concern I don't think Nasrat would have used his family IRA to load up 700k more shares a few weeks back.
"predicting a sudden move up with no lookback"
I agree I think there will be a violent upward move, maybe in the next few weeks and we will never see this level or anything close to it again.
The tech is plug and play, the potential is huge and Elite is a great position.
"350% since 8/5/13 down from 1325% in March of 2014"
Ya we will hear the same thing after the next run and pull back.
We are only up 400%, look what NH has done!! lol
What a joke.
GLTU
"blame the suckers and weak hands that sell to him below the ask."
Very true, very obvious.
The only things I would say is that their are some investors who may be tricked that I would not call suckers. My mom, who is heavily invested in Elite, could fall prey to such tactics.
Its sad, but het this is the wild wild west of the OTC's.
GLTA Longs
Plug and play, on all opioids and their dosages.
Thats what makes Elite's tech so unique and extremely valuable.
GLTA Longs
WHY is the company going no where?
What happened to the FDA meeting?
Where is Isradipine?
Isradipine will launch. (should happen before eoy)
THe meeting with the FDA is nor something they would PR. You will find out about the meeting at the next CC, call IR for questions.
The company has averaged over 70% rev growth over the last 7 Q's , launched 7 drugs in the last 2.5 years, no longer a going concern, started, finished several studies including Hal, doubled sq footage, doubled number of employees and many many more achievements. For those like you and I that were lucky enough to load below a dime have a several 100% gain.
IMO a buy in here is like a buy below a dime this time last year.
IMO last chance around or just below .30.
Was not that long ago when it was last chance below a dime.
IMO lots of great things happening behind the scenes.
I expect the CC to be very positive for longs and the share price.
Not what I have expected and predicted from past CC, when I expected no positive share price movement from CC.
GLTA Longs
Picked up a few more shares this AM.
Can't resist, the ceo just bought a bunch at this level and its 13% below Couch's buy signal.
Last time I bought 13% below his buy signal I found myself up by 300% a short time later.
A no brainer.
DEFINITION OF 'EARNINGS'
The amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. Earnings typically refer to after-tax net income.Ultimately, a business's earnings are the main determinant of its share price, because earnings and the circumstances relating to them can indicate whether the business will be profitable and successful in the long run.
"ART is coming and not a damn thing anybody here is going to do about it!! LOL LOL!!!"
Everything else, is simply noise.
But......
Glad I did not listen to the noise at .068. lol
"before we know it, we are above the dollar land!"
Yes sir I agree. All you have to do is take a few hours and learn a little bit about the fundamentals of this company and it's science, and you will realize this stock is not your normal otc stock and won't be under a dollar much longer.
Spoke with Dianne for a 1/2 hour this afternoon.
Elite is hitting on all cylinders.
May add a few more in the next week.
Lots of activity going on, we will hear about it it in 2 weeks or less.
From previous CC
In October, once we meet with the FDA, we’ll have them give us an assessment of the adequacy of all the data generated. Now we all interpret the regulations. We believe this is what we need to do, and then the FDA will tell you if you've gone to their standards or to their taste or not. So we will have a lot of feedback hopefully after October from the FDA.
Again, my vision is and has been for the past year and I’ll updated this with every single meeting. And it was the full order of my staff to deliver a filing by December of this year, and we are on target to do that. The only thing that could delay us, as I said before, no one can stop us. Elite’s anti-abuse is coming to the market. The only entity that could delay it is if the FDA requested one more clinical trial, which will put us on lab out six months. We will know about that once we meet with them in October.
Next step, what are we thinking about once we file. We believe the FDA will grant us expedited review and we’ll give us results probably by – or approval by September of 2015. That will be the date where we’d be launching and about a year from now, August, September of 2015. To do so we have to decide what we’re doing our product. I have made the decision we will be manufacturing ELI-200 ourselves.
I have had several companies that approached me and asked if contract manufacture for us, they have much bigger facilities and I've decided the product is staying with us. The marketing of the product, we have one of a couple of options. We either contract the sales and marketing force, and Chris and I have been in contact with such entities and got proposals and numbers and what have you.
And the second is to have a well-established pharmaceutical company that has the capabilities and sales and marketing force of 150 to 200 people that can sell our product in addition to this at some kind of a profit sharing or commission. I have not made the decision on that part and that will have to be made by December once we file, okay.
This is the status of the ELI-200. It is the most exciting product we have right now. We are filing an application, which have never happened in the history of this company. We’re launching an awesome product. I mean this is exceptionally exciting.
They have no communication with shareholders.
Any one heard back from IR?
Incredible.
Very well put,
Thanks for posting
Yes this stock is a rare find imo.
There are about 10 things I can think of, like CEO purchasing huge amounts of shares on the open market, that you won't find in any other otc stocks.
Wow that is 100% increase form the recent .07 prediction.
You are catching on.
John_Langston Member Level Tuesday, 05/20/14 02:43:50 PM
Re: rdragon post# 109472
Post # of 109489
We will probably hear it again at 0.07. LOL
Although small compared to what it will be in a few short months, it is nice to see.
More and more institutions taking starter positions.
Thanks for posting.